Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From Patient-Reported
Zuzanna Wójcik1, Vania Dimitrova2, Lorraine Warrington3
1UKRI Centre for Doctoral Training in Artificial Intelligence for Medical Diagnosis and Care, University of Leeds, Leeds, United Kingdom.
JCO Clinical Cancer Informatics
|April 26, 2024
Summary
Patient-reported outcome measures (PROMs) enhance machine learning (ML) models for predicting hospital admissions and chemotherapy changes. Balancing data significantly improved model performance for better patient care.
Area of Science:
- Oncology
- Health Informatics
- Machine Learning
Background:
- Adverse chemotherapy effects frequently lead to hospital admissions and treatment adjustments.
- Identifying predictors of unplanned hospital utilization is crucial for enhancing healthcare quality and patient well-being.
Purpose of the Study:
- To evaluate if patient-reported outcome measures (PROMs) improve the predictive performance of machine learning (ML) models.
- To predict hospital admissions, triage events, and chemotherapy modifications using ML models incorporating PROMs.
Main Methods:
- Utilized clinical trial data from 508 participants undergoing chemotherapy.
- Compared six feature sets (clinical data, PROMs, and combinations) across six ML models (logistic regression, decision tree, adaptive boosting, random forest, SVMs, neural network).
- Assessed model performance in predicting hospital admissions, triage events, and chemotherapy changes, considering data imbalance.
Main Results:
- PROMs significantly improved the prediction accuracy for all studied outcomes.
- Random Forest and SVM models demonstrated the highest performance for predicting admissions and chemotherapy changes in balanced datasets.
- Logistic Regression performed best on imbalanced datasets, and data balancing generally led to superior predictive performance.
Conclusions:
- Machine learning models applied to PROM data can effectively predict hospital utilization and chemotherapy management.
- This approach holds potential for improving healthcare planning and enabling personalized cancer treatment.
- The study highlights best practices in ML research by comparing methods for handling imbalanced data.
Related Concept Videos
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K


